Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc. (TSX: CRDL) is trading at CA$2.41, about ₹163 at today's CAD/INR rate, as of 29 Sep 2026, 4:00 PM ET, up 0.84% today. Indian residents can buy Cardiol Therapeutics from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
CA$2.38
Today's high
CA$2.42
52 week low
CA$1.23
52 week high
CA$3.23
CRDL opened at CA$2.38, closed previously at CA$2.39, and has traded between CA$1.23 and CA$3.23 over the past 52 weeks.
About
Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company, primarily engaged in the discovery and advancement of treatments designed to combat fibrosis and inflammation within the context of cardiovascular diseases. Its flagship product, CardiolRx, is currently undergoing a significant Phase II/III international clinical trial. This extensive study is randomized, double-blind, and placebo-controlled, evaluating CardiolRx's efficacy and safety as a heart-protective therapy to mitigate cardiovascular and respiratory issues in individuals hospitalized with COVID-19. Concurrently, the trial also assesses CardiolRx's role in addressing acute myocarditis. Beyond this, the company is developing an injectable, subcutaneous formulation of CardiolRx, intended to target cardiac scarring and inflammation that contribute to the development and worsening of heart failure. Established in 2017, Cardiol Therapeutics Inc. is based in Oakville, Canada.
Key statistics
Avg. volume
160.31K
Market cap
CA$277.81M
P/E Ratio
-7.00
Price-to-sales ratio
0.00
Enterprise value
CA$92.66M
Free cash flow yield
-20.95%
Debt-to-equity ratio
0.00
Return on equity
-189.17%
ROIC
-190.61%
Beta
0.47
Dividend yield
0.00%
Last dividend
CA$0.00
Financial overview
Revenue
CA$0.00
Earnings per share
-CA$0.39
Free cash flow
-CA$23.88M
Net profit margin
0.00%
Gross margin
0.00%
EBITDA
-CA$34.21M
Revenue growth
0.00%
Similar securities
This is not an investment recommendation
How to buy Cardiol Therapeutics from India
Indian residents can buy Cardiol Therapeutics shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to CAD.
Search for Cardiol Therapeutics and place an order
Find Cardiol Therapeutics by name or by its ticker, CRDL, and choose an order type. Cardiol Therapeutics trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Cardiol Therapeutics position in CAD and INR. Cardiol Therapeutics pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Cardiol Therapeutics from India
Trading and taxes when buying Cardiol Therapeutics from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneCardiol Therapeutics does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Cardiol Therapeutics stock?
Yes. Cardiol Therapeutics (CRDL) has been listed on the Toronto Stock Exchange since 2018, in the Drug Manufacturers - Specialty & Generic industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to CAD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Cardiol Therapeutics share cost in rupees?
One Cardiol Therapeutics share is CA$2.41 — about ₹163 at a CAD/INR rate of 67.65 on 29 Sep 2026. Both the Cardiol Therapeutics price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Cardiol Therapeutics from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
How are gains on Cardiol Therapeutics shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the CAD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Cardiol Therapeutics price. Paasa issues a capital-gains statement for your return.
Does Cardiol Therapeutics pay a dividend?
No. Cardiol Therapeutics does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Cardiol Therapeutics from India?
The Toronto Stock Exchange trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when Canada is on standard time. Orders can only execute during that window.
Do I have to declare Cardiol Therapeutics shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Cardiol Therapeutics holding, its cost and its closing value.
How do I sell Cardiol Therapeutics and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in CAD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.
Does the rupee rate affect what I make on Cardiol Therapeutics?
Yes. Cardiol Therapeutics is priced in CAD, so your rupee outcome combines the CAD move with the CAD/INR move between the day you remit and the day you convert back. Both directions are reflected in the capital-gains statement Paasa issues.